Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karijn P M Suijkerbuijk

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 11, 2017
Diarrhoea during checkpoint blockade, not always colitisJosephine J Koldenhof, Karijn P M Suijkerbuijk
Nature Reviews. Rheumatology|June 9, 2021
TNF inhibition for immune checkpoint inhibitor-induced irAEs: the jury is still outKarijn P M Suijkerbuijk, Rik J Verheijden
JAMA Oncology|June 20, 2020
Management of Immune-Related Adverse Events Affecting Outcome in Patients Treated With Checkpoint InhibitorsKarijn P M Suijkerbuijk, Ellen Kapiteijn, Rik J Verheijden
JAMA Oncology|March 9, 2023
Steroid Dose and Duration, Immortal Time Bias, and Survival After High-grade Immune-Related Adverse Events-ReplyOlivier J van Not, Rik J Verheijden, Karijn P M Suijkerbuijk
Frontiers in Oncology|March 1, 2021
Biomarkers of Checkpoint Inhibitor Induced Immune-Related Adverse Events-A Comprehensive ReviewJosefien W Hommes, Rik J Verheijden, Karijn P M Suijkerbuijk, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 12, 2008
Molecular analysis of nipple fluid for breast cancer screeningKarijn P M Suijkerbuijk, Elsken van der Wall, Marc Vooijs, et al.
Annals of Internal Medicine|September 20, 2021
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune DiseaseMonique K van der Kooij, Karijn P M Suijkerbuijk, Olaf M Dekkers, et al.
International Journal of Surgery Case Reports|March 17, 2022
Diagnostic pitfalls after COVID-19 vaccination in melanoma and breast cancer patients: A case seriesEllen de Bock, Kari Trumpi, Karijn P M Suijkerbuijk, et al.
Analytical Cellular Pathology (Amsterdam)|October 28, 2010
Comparison of different promoter methylation assays in breast cancerKarijn P M Suijkerbuijk, Xiaojuan Pan, Elsken van der Wall, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2022
Metachronous malignancies after response to checkpoint inhibitionMirjam A de Visser, Francois B Verschaeve, Lot A Devriese, et al.
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|October 11, 2017
Diarrhoea during checkpoint blockade, not always colitisJosephine J Koldenhof, Karijn P M Suijkerbuijk
Nature Reviews. Rheumatology|June 9, 2021
TNF inhibition for immune checkpoint inhibitor-induced irAEs: the jury is still outKarijn P M Suijkerbuijk, Rik J Verheijden
JAMA Oncology|June 20, 2020
Management of Immune-Related Adverse Events Affecting Outcome in Patients Treated With Checkpoint InhibitorsKarijn P M Suijkerbuijk, Ellen Kapiteijn, Rik J Verheijden
JAMA Oncology|March 9, 2023
Steroid Dose and Duration, Immortal Time Bias, and Survival After High-grade Immune-Related Adverse Events-ReplyOlivier J van Not, Rik J Verheijden, Karijn P M Suijkerbuijk
Frontiers in Oncology|March 1, 2021
Biomarkers of Checkpoint Inhibitor Induced Immune-Related Adverse Events-A Comprehensive ReviewJosefien W Hommes, Rik J Verheijden, Karijn P M Suijkerbuijk, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 12, 2008
Molecular analysis of nipple fluid for breast cancer screeningKarijn P M Suijkerbuijk, Elsken van der Wall, Marc Vooijs, et al.
Annals of Internal Medicine|September 20, 2021
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune DiseaseMonique K van der Kooij, Karijn P M Suijkerbuijk, Olaf M Dekkers, et al.
International Journal of Surgery Case Reports|March 17, 2022
Diagnostic pitfalls after COVID-19 vaccination in melanoma and breast cancer patients: A case seriesEllen de Bock, Kari Trumpi, Karijn P M Suijkerbuijk, et al.
Analytical Cellular Pathology (Amsterdam)|October 28, 2010
Comparison of different promoter methylation assays in breast cancerKarijn P M Suijkerbuijk, Xiaojuan Pan, Elsken van der Wall, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2022
Metachronous malignancies after response to checkpoint inhibitionMirjam A de Visser, Francois B Verschaeve, Lot A Devriese, et al.
Pageof 13